Evaluating True PCR-negative Rate of Frontline Dasatinib in Early Chronic Phase CML for Therapeutic Harmonization

计划入组 102 人 · 首次发布于 2016 年 11 月 29 日

KOrea COpd Subgroup Registry and Subtype Research

计划入组 2,000 人 · 首次发布于 2016 年 6 月 15 日

Eligibility Screening for National Institute of Dental and Craniofacial Research Studies

计划入组 300 人 · 首次发布于 2000 年 1 月 27 日

KBH-A402

KR-69530

long-acting insulin analogs (Institute of Biotechnology and Antibiotics/IBAkteria)

Korea Advanced Institute of Science and Technology

South Korea

Korea Food Research Institute

South Korea

Korea Institute of Oriental Medicine

South Korea

Korean Researchers Develop Precision Nanobody Therapy for Lung Adenocarcinoma with 90% Tumor Reduction

BioTNS to Lead $19.5M South Korean Government Program for Ultra-Precision Digital PCR Standards

CHA Biotech Secures Government Backing to Advance Cell and Gene Therapy Platforms Toward Clinical Development